Q32 Bio to Participate in Upcoming September Investor Conferences
Conor Tierney will discuss AEye’s lidar products and outlook and meet investors one on one at the conference, the company said.
- On August 31, 2026, Palladyne AI , a U.S.-based aerospace, defense and industrial technology company, announced that Chief Executive Officer Ben Wolff and Chief Financial Officer Trevor Thatcher will participate in two upcoming investor conferences in September.
- Investor conferences serve as critical platforms for management teams to connect with the investment community and present strategic initiatives. Companies including BridgeBio Pharma and Rocket Pharmaceuticals use these forums to highlight clinical progress and commercialization timelines.
- Wolff and Thatcher will participate in the Jefferies Global Industrials Conference on September 9 at 8:10 a.m. ET and the Lake Street Capital Markets 10th Annual Best Ideas Growth Conference on September 10. One-on-one meetings with registered investors are also scheduled.
- Investors unable to attend in person can access live webcasts through dedicated investor relations sections on company websites. Archived replays will be available for 90 days following each event, broadening access to presentations.
- The active conference schedule reflects broader industry focus on translational science, ranging from aerospace autonomy to gene-editing therapeutics. Companies view these engagements as essential opportunities to clarify commercialization pathways and demonstrate long-term growth potential to capital markets.
29 Articles
29 Articles
Longeveron to Present at the H.C. Wainwright 28th Annual Global Investment Conference
MIAMI, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that it will participate in the H.C. Wainwright 28th Annual Global…
Medicenna to Present at the H.C. Wainwright 28th Annual Global Investment Conference
TORONTO and HOUSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines targeting cancer, autoimmune, and inflammatory diseases, announced today that Dr.…
Herald & Review
stocktitan.netTETRA TECHNOLOGIES, INC. TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
SPRING, Texas, Sept. 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) announced that Brady Murphy, Chief Executive Officer, and Kurt Hallead, Treasurer and VP of Investor Relations, will be meeting with institutional investors at the…
Morgan County Citizen
inovio.comINOVIO to Participate in Upcoming Investor Conferences
PLYMOUTH MEETING, Pa., Sept. 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in…
Coverage Details
Bias Distribution
- 67% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
